Clin2
NCT04786262Possibly a fitRecruiting

A study of VX-880 and VX-017 for type 1 diabetes

Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This study tests two investigational drugs, VX-880 and VX-017, for people with type 1 diabetes who have trouble controlling their blood sugar and have frequent severe low blood sugar episodes. The goal is to see if these drugs can improve blood sugar control and reduce dangerous lows.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
57 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have type 1 diabetes and have needed insulin for at least 5 years.
  • You've had at least two severe low blood sugar events in the last 12 months.
  • Your diabetes treatment is stable and you've been using a continuous glucose monitor (CGM) for at least 3 months.
  • You have not had an islet cell transplant, organ transplant, or cell therapy before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07126873Recruiting· Phase 1/Phase 2
Study of E-islet 01 for type 1 diabetes with severe low blood sugar

This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.

Shanghai, Shanghai Municipality
NCT06731218Recruiting· Phase 1
A study on RGB-5088 for type 1 diabetes

This trial tests a new treatment called RGB-5088 in people with type 1 diabetes. It aims to see if the treatment is safe and if it helps control blood sugar.

Tianjin, Tianjin Municipality
NCT06832410Recruiting· Phase 3
Testing VX-880 for type 1 diabetes with a kidney transplant

This trial tests a new treatment called VX-880 for people who have had type 1 diabetes for at least 5 years and have already received a kidney transplant. The goal is to see if VX-880 can improve blood sugar control while you continue your current transplant medications.

Philadelphia, Pennsylvania
NCT06474598Recruiting· Phase 2
Test of MTX228 for type 1 diabetes with some insulin

This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.

Edmonton, Alberta
NCT07340320Recruiting· Phase 2
CX11 tablets for type 2 diabetes

This trial tests an experimental drug called CX11 to see if it helps control blood sugar in people with type 2 diabetes who are already taking metformin. It may be an option for you if your blood sugar is not well controlled and you meet the health requirements.

Birmingham, Alabama
NCT07699380Recruiting· Phase 2
Metabolic therapy to improve insulin sensitivity in type 1 diabetes

This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.

Seattle, Washington

Hear when a new Severe Hypoglycemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.